Prostate Cancer Academy 2024 to Be Held in Dallas

Registration Open  

April 4-6, 2024:  Prostate Cancer Academy  –  Westin Irving Convention Center, Dallas, Texas

Hosted by Specialty Networks and LUGPA, the Prostate Cancer Academy brings together those who have an active interest in increasing the quality and scope of care for prostate cancer patients in their practices.

Receive an intensive education on the most recent breakthroughs & approvals for all stages of prostate cancer. Our expert faculty will present, discuss, and debate all available preventative, diagnostic, therapeutic, and management options for prostate cancer in a highly interactive format, via didactic lectures as well as case-based and panel discussions. The meeting will start with a networking reception on Thursday afternoon and end Saturday mid-morning.

AGENDA NOW AVAILABLE - New! 
View the Agenda Here


Learn more and register here.

 

If you have questions about registration, please contact Katie O’Donnell, [email protected].

The 100 available registration slots have been allocated by role: 70 MDs and 30 residents. (Slots for APPs and Patient Navigators may be made available at a future date.)

Hotel and travel reimbursement available. There is no cost to register. Hotel accommodations for a 2-night stay at the Westin Irving at Las Colinas, in accordance with the meeting, will be provided for attendees (not exhibitors). Learn more about hotel and travel reimbursement here.  

CO-DIRECTORS

Neal Shore, MD, FACS,
U.S. Chief Medical Officer,
Urology & Surgery,
GenesisCare U.S.

David Morris, MD, FACS,
President, Urology Associates, PC

 

Read all about the 2023 event here.

Hosted by Specialty Networks and LUGPA, the Prostate Cancer Academy brings together those who have an active interest in increasing the quality and scope of care for prostate cancer patients in their practices.

     
     

The 2023 event took place May 18-20 outside of Dallas with 88 participants in attendance (including faculty). The meeting was a unique opportunity for attendees to interact with the top thought leaders who play pivotal roles in advancing the treatment of prostate cancer. 

Lectures and discussions were held on the most recent breakthroughs and approvals for all stages of prostate cancer. Expert faculty presented, discussed, and debated diagnostic and therapeutic options for prostate cancer via didactic lectures as well as case-based and panel discussions. 

The meeting started with a networking reception on Thursday evening and ended Saturday mid-morning.  Among the faculty were Matthew Cooperberg, MD, MPH, Scot Davis, MPA, MBA, CMPE, Michael Fabrizio, MD, FACS, Tom Jayram, MD, Vahan Kassabian, MD, Phil Koo, MD, Bryan Mehlhaff, MD, David Morris, MD, Tim Richardson, MD, Scott Sellinger, MD, Neal Shore, MD, FACS, and many more. 

Photos from the event can be found on Specialty Network’s LinkedIn page, as well as LUGPA’s Facebook and Twitter sites.